BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
Clinical trial NCT04296942 · TERMINATED
Trial details
- NCT number
- NCT04296942
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-04
- Primary completion
- 2021-10-22
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.